WEDNESDAY, Sept. 3, 2014 -- A cancer drug that targets the immune system may help improve the outlook for older adults with multiple myeloma , though a stem cell transplant remains the standard of care for relatively younger patients.
http://ift.tt/1xg4OV8
http://ift.tt/1xg4OV8
No comments:
Post a Comment